Integrated community-based intervention for urinary schistosomiasis and soil-transmitted helminthiasis in children from Caxito, Angola.
Adolescent
Albendazole
/ therapeutic use
Angola
/ epidemiology
Animals
Anthelmintics
/ therapeutic use
Child
Child, Preschool
Community Health Services
/ organization & administration
Feces
/ parasitology
Female
Helminthiasis
/ drug therapy
Humans
Male
Mass Drug Administration
Praziquantel
/ therapeutic use
Prevalence
Program Evaluation
Prospective Studies
Schistosoma haematobium
/ isolation & purification
Schistosomiasis haematobia
/ drug therapy
Soil
/ parasitology
Urine
/ parasitology
Schistosomiasis haematobia
chemotherapy
mass drug administration
soil-transmitted helminths
Journal
International health
ISSN: 1876-3405
Titre abrégé: Int Health
Pays: England
ID NLM: 101517095
Informations de publication
Date de publication:
12 02 2020
12 02 2020
Historique:
received:
11
03
2019
revised:
24
05
2019
accepted:
07
06
2019
pubmed:
11
7
2019
medline:
29
4
2020
entrez:
11
7
2019
Statut:
ppublish
Résumé
Schistosomiasis and soil-transmitted helminths (STH) infections are major public health problems. We aimed to study the 6-mo impact of mass drug administration with praziquantel and albendazole on urinary schistosomiasis and STH. We examined children (aged 2-15 y) from one hamlet, who provided urine and faeces samples at baseline (n=197), 1 mo (n=102) and 6 mo (n=92); 67 completed the protocol. At baseline, 47/67 (70.1%) children presented Schistosoma haematobium (75.8% in the baseline total sample) and 12/67 (17.9%) with STH (30.5% in the initial sample, p=0.010). Among the children, 47.3% had heavy Schistosoma haematobium infection. The most frequent STH was Trichuris trichiura in 9.0%. We also found Hymenolepis nana (13.2%) and Plasmodium falciparum (9.1%) infections and anaemia (82.1%). One mo after chemotherapy there was a significant (p=0.013) reduction of Schistosoma haematobium prevalence (23.5%) and a high egg reduction rate (86.9%). Considering the sample of 67 children, the mean egg concentration was 498 at baseline, 65 at 1 mo and 252 at 6 mo (p<0.05). We also observed a reduction in STH infections, 50% in Ascaris lumbricoides, 33.3% in T. trichiura and 50% in hookworms. At 6 mo, the prevalence of Schistosoma haematobium (76.1%) was similar to the baseline and the STH reduction was not significant. Longitudinal studies have reported many losses in these settings, but we were able to show that mass drug administration for control of schistosomiasis and STH present low effectiveness, that reinfections occur rapidly and that stand alone anthelmintic therapy is not a sustainable choice.
Sections du résumé
BACKGROUND
Schistosomiasis and soil-transmitted helminths (STH) infections are major public health problems. We aimed to study the 6-mo impact of mass drug administration with praziquantel and albendazole on urinary schistosomiasis and STH.
METHODS
We examined children (aged 2-15 y) from one hamlet, who provided urine and faeces samples at baseline (n=197), 1 mo (n=102) and 6 mo (n=92); 67 completed the protocol.
RESULTS
At baseline, 47/67 (70.1%) children presented Schistosoma haematobium (75.8% in the baseline total sample) and 12/67 (17.9%) with STH (30.5% in the initial sample, p=0.010). Among the children, 47.3% had heavy Schistosoma haematobium infection. The most frequent STH was Trichuris trichiura in 9.0%. We also found Hymenolepis nana (13.2%) and Plasmodium falciparum (9.1%) infections and anaemia (82.1%). One mo after chemotherapy there was a significant (p=0.013) reduction of Schistosoma haematobium prevalence (23.5%) and a high egg reduction rate (86.9%). Considering the sample of 67 children, the mean egg concentration was 498 at baseline, 65 at 1 mo and 252 at 6 mo (p<0.05). We also observed a reduction in STH infections, 50% in Ascaris lumbricoides, 33.3% in T. trichiura and 50% in hookworms. At 6 mo, the prevalence of Schistosoma haematobium (76.1%) was similar to the baseline and the STH reduction was not significant.
CONCLUSIONS
Longitudinal studies have reported many losses in these settings, but we were able to show that mass drug administration for control of schistosomiasis and STH present low effectiveness, that reinfections occur rapidly and that stand alone anthelmintic therapy is not a sustainable choice.
Identifiants
pubmed: 31290969
pii: 5530565
doi: 10.1093/inthealth/ihz055
pmc: PMC7057141
doi:
Substances chimiques
Anthelmintics
0
Soil
0
Praziquantel
6490C9U457
Albendazole
F4216019LN
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
86-94Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Acta Trop. 2013 Nov;128(2):275-83
pubmed: 23791803
Lancet. 2010 Nov 6;376(9752):1592-603
pubmed: 21035841
PLoS Med. 2016 Jan 19;13(1):e1001942
pubmed: 26783752
Am J Trop Med Hyg. 2004 Dec;71(6):778-82
pubmed: 15642971
PLoS Negl Trop Dis. 2015 Jan 08;9(1):e3423
pubmed: 25569278
PLoS One. 2012;7(4):e33189
pubmed: 22493664
Am J Trop Med Hyg. 2013 Sep;89(3):540-8
pubmed: 23836564
Geospat Health. 2013 May;7(2):341-54
pubmed: 23733295
Int J Parasitol Drugs Drug Resist. 2011 Oct 14;1(1):14-27
pubmed: 24533260
Malar J. 2012 Nov 22;11:385
pubmed: 23173636
Parasitology. 1983 Oct;87 (Pt 2):343-69
pubmed: 6359028
PLoS One. 2014 Mar 18;9(3):e92032
pubmed: 24643023
PLoS Negl Trop Dis. 2012;6(4):e1549
pubmed: 22545163
Parasit Vectors. 2012 Jun 07;5:108
pubmed: 22676052
Acta Trop. 2013 Nov;128(2):182-95
pubmed: 23973364
Parasit Vectors. 2015 Aug 25;8:436
pubmed: 26302747
PLoS Negl Trop Dis. 2012;6(9):e1783
pubmed: 23029572
BMJ. 2000 Jun 24;320(7251):1697-701
pubmed: 10864543
BMC Public Health. 2017 Oct 10;17(1):791
pubmed: 29017470
BMC Infect Dis. 2004 Aug 13;4:27
pubmed: 15310401
PLoS Negl Trop Dis. 2017 Aug 3;11(8):e0005424
pubmed: 28771480
Afr Health Sci. 2016 Sep;16(3):698-703
pubmed: 27917202
J Clin Invest. 2008 Apr;118(4):1311-21
pubmed: 18382743
Int J Parasitol. 2005 Nov;35(13):1453-7
pubmed: 16002073